These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11586956)

  • 21. Expression of the X-linked agammaglobulinemia gene, btk in B-cell acute lymphoblastic leukemia.
    Katz FE; Lovering RC; Bradley LA; Rigley KP; Brown D; Cotter F; Chessells JM; Levinsky RJ; Kinnon C
    Leukemia; 1994 Apr; 8(4):574-7. PubMed ID: 8152253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia.
    Vihinen M; Kwan SP; Lester T; Ochs HD; Resnick I; Väliaho J; Conley ME; Smith CI
    Hum Mutat; 1999; 13(4):280-5. PubMed ID: 10220140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of lymphocyte subpopulations and the expression of activation markers in diabetes mellitus types 1 and 2].
    Salozhin KV; Nasonov EL; Sura VV; Aleksandrova EN; Gracheva LA
    Klin Med (Mosk); 1989 Oct; 67(10):118-21. PubMed ID: 2693822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Agammaglobulinemia as early B cell defects].
    Miyawaki T; Kanegane H; Futatani T
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Oct; 23(5):435-44. PubMed ID: 11155713
    [No Abstract]   [Full Text] [Related]  

  • 25. Neutropenia associated with X-linked agammaglobulinaemia.
    Kozlowski C; Evans DI
    J Clin Pathol; 1991 May; 44(5):388-90. PubMed ID: 2045497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The level of circulating cytokines and chemokines in the preclinical and early clinical stages of type IA diabetes mellitus development].
    Zak KP; Popova VV; Mel'nichenko SV; Tron'ko EN; Man'kovskiĭ BN
    Ter Arkh; 2010; 82(10):10-5. PubMed ID: 21341456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
    Hagemann TL; Rosen FS; Kwan SP
    Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
    J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The molecular genetic aspects of insulin-dependent diabetes mellitus].
    Pankov IuA; Chekhranova MK; Butnev VIu
    Probl Endokrinol (Mosk); 1990; 36(4):3-11. PubMed ID: 2235930
    [No Abstract]   [Full Text] [Related]  

  • 31. Echovirus 11 arthritis in a patient with X-linked agammaglobulinemia.
    Ackerson BK; Raghunathan R; Keller MA; Bui RH; Phinney PR; Imagawa DT
    Pediatr Infect Dis J; 1987 May; 6(5):485-8. PubMed ID: 3601497
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia.
    Conley ME; Howard V
    J Pediatr; 2002 Oct; 141(4):566-71. PubMed ID: 12378199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [X-linked hypogammaglobulinemia with growth hormone deficiency].
    Saito M; Kanegane H; Miyawaki T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):69-71. PubMed ID: 11212826
    [No Abstract]   [Full Text] [Related]  

  • 34. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.
    Lin MT; Chien YH; Shyur SD; Huang LH; Chiang YC; Wen DC; Liang PH; Yang HC
    Ann Allergy Asthma Immunol; 2006 May; 96(5):744-8. PubMed ID: 16729790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel insertions of Bruton tyrosine kinase in patients with X-linked agammaglobulinemia.
    Okoh MP; Kainulainen L; Heiskanen K; Isa MN; Varming K; Ruuskanen O; Vihinen M
    Hum Mutat; 2002 Dec; 20(6):480-1. PubMed ID: 12442285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
    Wang Y; Kanegane H; Sanal O; Ersoy F; Tezcan I; Futatani T; Tsukada S; Miyawaki T
    Hum Mutat; 2001 Oct; 18(4):356. PubMed ID: 11668622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral T cells in diabetes prone (DP) BB rats are CD45R-negative.
    Groen H; van der Berk JM; Nieuwenhuis P; Kampinga J
    Thymus; 1989; 14(1-3):145-50. PubMed ID: 2533758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
    Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.